Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.

AIMS The reaction of nitric oxide and nitrite-derived species with polyunsaturated fatty acids yields electrophilic fatty acid nitroalkene derivatives (NO2-FA), which display anti-inflammatory properties. Given that the 5-lipoxygenase (5-LO, ALOX5) possesses critical nucleophilic amino acids, which are potentially sensitive to electrophilic modifications, we determined the consequences of NO2-FA on 5-LO activity in vitro and on 5-LO-mediated inflammation in vivo. RESULTS Stimulation of human polymorphonuclear leukocytes (PMNL) with nitro-oleic (NO2-OA) or nitro-linoleic acid (NO2-LA) (but not the parent lipids) resulted in the concentration-dependent and irreversible inhibition of 5-LO activity. Similar effects were observed in cell lysates and using the recombinant human protein, indicating a direct reaction with 5-LO. NO2-FAs did not affect the activity of the platelet-type 12-LO (ALOX12) or 15-LO-1 (ALOX15) in intact cells or the recombinant protein. The NO2-FA-induced inhibition of 5-LO was attributed to the alkylation of Cys418, and the exchange of Cys418 to serine rendered 5-LO insensitive to NO2-FA. In vivo, the systemic administration of NO2-OA to mice decreased neutrophil and monocyte mobilization in response to lipopolysaccharide (LPS), attenuated the formation of the 5-LO product 5-hydroxyeicosatetraenoic acid (5-HETE), and inhibited lung injury. The administration of NO2-OA to 5-LO knockout mice had no effect on LPS-induced neutrophil or monocyte mobilization as well as on lung injury. INNOVATION Prophylactic administration of NO2-OA to septic mice inhibits inflammation and promotes its resolution by interfering in 5-LO-mediated inflammatory processes. CONCLUSION NO2-FAs directly and irreversibly inhibit 5-LO and attenuate downstream acute inflammatory responses.

[1]  N. A. Stewart,et al.  Modulation of Nitro-fatty Acid Signaling , 2013, The Journal of Biological Chemistry.

[2]  N. A. Stewart,et al.  Modulation of Nitro-Fatty Acid Signaling: Prostaglandin Reductase-1 is a Nitroalkene Reductase , 2013 .

[3]  A. Reichert,et al.  Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex. , 2012, Cell metabolism.

[4]  O. Werz,et al.  Inhibition of 5-lipoxygenase by U73122 is due to covalent binding to cysteine 416. , 2012, Biochimica et biophysica acta.

[5]  P. Montuschi,et al.  New perspectives in pharmacological treatment of mild persistent asthma. , 2011, Drug discovery today.

[6]  G. Schneider,et al.  Dimerization of human 5-lipoxygenase , 2011, Biological chemistry.

[7]  B. Freeman,et al.  Formation and signaling actions of electrophilic lipids. , 2011, Chemical reviews.

[8]  C. Carlberg,et al.  Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* , 2011, Journal of Biological Chemistry.

[9]  M. Peters-Golden,et al.  Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. , 2011, The Journal of clinical investigation.

[10]  C. Funk Leukotriene Inflammatory Mediators Meet Their Match , 2011, Science Translational Medicine.

[11]  A. Brash,et al.  The Structure of Human 5-Lipoxygenase , 2011, Science.

[12]  S. Cuzzocrea,et al.  The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages , 2010, British journal of pharmacology.

[13]  M. Rossi,et al.  5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. , 2010, Microbes and infection.

[14]  B. Freeman,et al.  Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease , 2010, Annals of the New York Academy of Sciences.

[15]  Y. E. Chen,et al.  Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. , 2010, The Journal of biological chemistry.

[16]  B. Freeman,et al.  Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment. , 2010, Current opinion in pharmacology.

[17]  Hai-ying Liu,et al.  Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice. , 2010, American journal of physiology. Renal physiology.

[18]  S. Ylä-Herttuala,et al.  Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells , 2009, The Journal of Biological Chemistry.

[19]  Paolo Montuschi,et al.  LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  M. P. Cole,et al.  Nitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction* , 2009, Journal of Biological Chemistry.

[21]  Y. E. Chen,et al.  Nitro-Fatty Acid Inhibition of Neointima Formation After Endoluminal Vessel Injury , 2008, Circulation research.

[22]  M. Tarpey,et al.  Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase* , 2008, Journal of Biological Chemistry.

[23]  Y. E. Chen,et al.  Molecular recognition of nitrated fatty acids by PPARγ , 2008, Nature Structural &Molecular Biology.

[24]  P. Montuschi Leukotrienes, antileukotrienes and asthma. , 2008, Mini reviews in medicinal chemistry.

[25]  O. Werz,et al.  5-Lipoxygenase: regulation of expression and enzyme activity. , 2007, Trends in biochemical sciences.

[26]  Oliver Werz,et al.  Therapeutic options for 5-lipoxygenase inhibitors. , 2006, Pharmacology & therapeutics.

[27]  Jifeng Zhang,et al.  Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.

[28]  J. Janssens,et al.  [Leukotriene-modifiers in asthma treatment]. , 2006, Revue medicale suisse.

[29]  Y. Chen,et al.  Fatty Acid Transduction of Nitric Oxide Signaling , 2005, Journal of Biological Chemistry.

[30]  C. Funk Leukotriene modifiers as potential therapeutics for cardiovascular disease , 2005, Nature Reviews Drug Discovery.

[31]  Jifeng Zhang,et al.  Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand , 2005 .

[32]  N. Patel,et al.  Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5‐lipoxygenase knockout mice and by the 5‐lipoxygenase inhibitor zileuton , 2004, Journal of leukocyte biology.

[33]  A. Ramachandran,et al.  Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. , 2004, Biochemical Society transactions.

[34]  O. Werz,et al.  Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. , 2002, Blood.

[35]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[36]  B. Persson,et al.  The N-terminal Domain of 5-Lipoxygenase Binds Calcium and Mediates Calcium Stimulation of Enzyme Activity* , 2000, The Journal of Biological Chemistry.

[37]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[38]  H. Pahl Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[39]  O. Werz,et al.  Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. , 1996, European journal of biochemistry.

[40]  D. Steinhilber,et al.  Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Samuelsson,et al.  Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues. , 1993, The Journal of biological chemistry.

[42]  J. Thirion,et al.  Cloning of the guinea pig 5-lipoxygenase gene and nucleotide sequence of its promoter. , 1992, Biochemical and biophysical research communications.

[43]  R. Egan,et al.  Inhibition of mammalian 5-lipoxygenase by aromatic disulfides. , 1985, The Journal of biological chemistry.